In February, JPMorgan, Amazon, and Berkshire Hathaway ended Haven, a buzzy joint venture that sought to improve patient outcomes through better primary care and that shook up the entire healthcare world. Now, the banking giant is launching its own version of Haven: Morgan Health. Dan Mendelson, a healthcare consultant who previously served as the associate director for health at the Office of Management and Budget under the Clinton administration, will head up JPMorgan’s new health company. He says that Morgan Health will have the same goals as Haven did, in terms of improving quality, access, and cost, but differ in its approach. “The Haven experience focused us on primary care, digital medicine, and specific populations. . . . You can see this as a continuation of the work that was started at Haven,” he said in an interview with healthcare industry publication Becker’s Hospital Review . Haven was attempting to build a system from the ground up, he says. Instead of taking that approach, Morgan Health will focus on collaborating with outside partners to create a new health program for the bank’s 165,000 employees and their families. The goal of the new venture is to reinvent how employees receive their healthcare
The rest is here:
Haven is dead, but JPMorgan still wants to transform healthcare